Citadel Advisors’s Defiance Daily Target 2X Long ORCL ETF ORCX Stock Holding History

Citadel Advisors’s Portfolio ORCX Stock Details ORCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19M	Buy	94,287 +62,569	+197%	+$2.43M	﹤0.01%	6349
2026 Q1	$847K	Sell	31,718 -5,482	-15%	-$192K	﹤0.01%	8039
2025 Q4	$1.92M	Buy	+37,200	New	+$3.15M	﹤0.01%	5995

Other funds holding ORCX

CCM

Capstone Capital Management Hong Kong $224M AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $1.54B AUM 30.1% 1-Year Est. Return

Citadel Advisors's ORCX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Defiance Daily Target 2X Long ORCL ETF (ORCX) in Q2 2026: 107,622 shares worth $2.5M. The stake represents ﹤0.01% of the portfolio and ranks #6060 among its holdings.

13 funds tracked by Wall St. Rank hold ORCX as of Q2 2026.

Citadel Advisors held 107,622 shares of Defiance Daily Target 2X Long ORCL ETF worth $2.5M as of Q2 2026.
Defiance Daily Target 2X Long ORCL ETF was a new Citadel Advisors position in Q2 2026.
Defiance Daily Target 2X Long ORCL ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #6060 holding.
13 funds tracked by Wall St. Rank held Defiance Daily Target 2X Long ORCL ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.